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Abstract: The gastrointestinal (GI) tract is crucial for food digestion and nutrient absorption in humans.
However, the GI tract is usually challenged with oxidative stress that can be induced by various factors,
such as exogenous pathogenic microorganisms and dietary alterations. As a part of gut microbiota,
Lactobacillus spp. play an important role in modulating oxidative stress in cells and tissues, especially in
the GI tract. Oxidative stress is linked with excessive reactive oxygen species (ROS) that can be formed
by a few enzymes, such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs).
The redox mechanisms of Lactobacillus spp. may contribute to the downregulation of these ROS-forming
enzymes. In addition, nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf-2) and nuclear factor kappa B
(NF-κB) are two common transcription factors, through which Lactobacillus spp. modulate oxidative stress
as well. As oxidative stress is closely associated with inflammation and certain diseases, Lactobacillus spp.
could potentially be applied for early treatment and amelioration of these diseases, either individually or
together with prebiotics. However, further research is required for revealing their mechanisms of action
as well as their extensive application in the future.
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1. Introduction
The gastrointestinal (GI) tract, which comprises the oral cavity, esophagus, stomach, small intestine,
large intestine, rectum as well as anus, plays an important role regarding food intake, digestion and
nutrient absorption for humans and other mammals [1,2]. It is estimated that around 60 tons of foods will
pass through the human GI tract during a normal lifetime, along with potential threats and challenges,
which are primarily due to exogenous microbes [3]. There are few mechanisms that can protect the GI tract
against those threats and challenges as well as maintain its healthy condition. For example, the GI epithelial
cells and their secretion act as the major barrier which protects the GI tract from potential pathogens and
toxicants [3,4].
Apart from that, gut microbiota, as a complex group of microorganisms colonizing the GI tract,
are of significant importance with regard to health [5]. They may be considered as an extension of the
human body, and contribute to the gut integrity [6], nutrient metabolism [7] and metabolic homeostasis [8].
In addition, gut microbiota are also important to the GI immune surveillance since they contribute to
the development of the mucosal immune system in the GI tract [9]. Among the human gut microbiota,
Lactobacillus spp. are a minor but necessary member, which have been revealed to be frequently implicated
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in multiple diseases, and are closely associated with human health [10]. In recent years, there has been
an increasing number of Lactobacillus spp. consistently associated with the human GI tract [11]. A few
studies have reported the beneficial role of Lactobacillus spp. regarding the balance they are able to bring
to the gut microbiota. For example, supplementations of different combinations of L. fermentum and
L. plantarum have been reported to affect diversity and functionality of the gut microbiota in mice [12].
According to 16S rRNA (ribonucleic acid)-gene compositional data, the combination of two L. fermentum
strains (GOS47 and GOS1) may contribute to the enhanced anti-inflammatory activity of gut microbiota.
In addition, L. fermentum GOS57 and L. plantarum GOS42 altered the gut microbiota composition by
decreasing the amount of Enterobacteriaceae and increasing the amount of Lactobacillus spp.
Oxidative stress is an imbalance between the production of reactive oxygen species (ROS) and
their elimination, acted by protective mechanisms, namely antioxidant defenses [13]. Oxidative stress is
implicated in the natural aging process and the pathogenesis of numerous diseases [14]. Some studies
revealed that the low-grade inflammation involved in the pathogenesis of metabolic syndrome, such as
diabetes, might be due to different levels of oxidative stress [15,16]. With regard to oxidative stress occurring
in the GI tract, it has a close association with dietary structure and alterations of gut microbiota [13].
Importantly, diet is also a major factor in shaping the microbial colonization and their relative abundance
in the human GI tract [17]. As a result of the beneficial role of gut microbiota, there has been an increasing
focus regarding their positive impacts on oxidative stress and the pathogenesis of relevant diseases [18].
Thus, it is highly probable that the redox state of the GI tract could be maintained by gut microbiota, such as
Lactobacillus spp. This review will discuss the potential of Lactobacillus spp. for modulating oxidative stress
in the GI tract, with emphases on their redox mechanisms and possible application.
2. Oxidative Stress
2.1. Reactive Oxygen Species (ROS)
Oxidative stress describes the situation in which the antioxidant capacity and metabolic regulation
of cells are overwhelmed due to excessive oxygen radicals, namely ROS [19,20]. The relatively narrow
definition of ROS includes ozone (O3), singlet oxygen (1O2) as well as reactive oxygen intermediates (ROI)
involving hydroxyl radicals (•OH), hydrogen peroxide (H2O2) and superoxide radical anion (O2•−) that are
formed on the basis of incomplete reduction of molecular oxygen [21]. More generally, compounds such
as hypochlorous (HOCl), and incorporation of radicals like peroxyl (ROO•) or organic hydroperoxides
(ROOH), are also defined as ROS [22,23]. ROS could be regarded as natural by-products as a result of the
metabolism of oxygen. Furthermore, ROS are important regarding the expression of some transcription
factors and signal transduction molecules [24], and can also regulate cell adhesion and participate in
intracellular signaling processes regarding apoptosis, cell overgrowth and others [25,26]. However, ROS are
considered as damaging agents if they are formed excessively in living organisms.
As compared to exogenous sources of ROS, such as ultraviolet light and ionizing radiation,
their endogenous sources are more crucial, which are implicated in a wide range of mechanisms
within humans and other animals [27]. Various enzymes could be the intracellular sources of ROS.
Cytosolic enzyme systems, typically nicotinamide adenine dinucleotide phosphate (NADPH) oxidases
(NOXs), can generate O2•− through transferring an electron to a FAD (flavin adenine dinucleotide) cofactor
and further passing it to a haem group, which is conducted by cytosolic domains of NOXs [28]. However,
there might be different biological outcomes in response to the various expression of NOXs in different
cells. In addition to NOXs, mitochondria are another major intracellular source of ROS, which produce
ROS primarily through electron leakage from Complex I (NADH dehydrogenase) as well as Complex
III (ubiquinol–cytochrome c oxidoreductase), namely, two discrete points in the electron transporting
chain [29,30]. Apart from the above, other endogenous sources of ROS are enzymes including xanthine
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oxidoreductase (XOR), cytochrome P450 family (CYPs), cyclooxygenase (COX) and lipoxygenase (LOX),
as well as a few peroxisomal oxidases [31,32]. The ROS level normally remains very low inside the
cells as a result of the well-developed antioxidant systems in eukaryotes, which can be classified as two
categories, including ROS scavenging enzymes such as superoxide dismutase (SOD) and catalase, as well
as non-enzymatic antioxidants like glutathione (GSH) and flavonoids [33]. However, the ROS level could
increase due to many factors, such as suppression and inactivation of antioxidant enzymes, which will
result in the imbalance between the production and elimination of ROS [25].
2.2. Diet, Gut Microbiota and Oxidative Stress
Oxidative stress could have deleterious impacts on various organs and systems throughout the
body, such as the heart, kidney, liver and pancreas [26,34,35]. Apart from that, the GI tract is also where
oxidative stress usually emerges, which is closely associated with alterations of the gut microbiota as well
as diet [13]. Diet imparts a considerable impact on both colonization and abundance of the gut microbiota
irrespective of the age. Different dietary components, such as dietary fiber, fat and minerals, can affect the
gut microbiota differently; for example, dietary fiber, which contains resistant starch, could contribute to
diversity of the gut microbiota [36]. In addition, it has been demonstrated that soluble fiber can maintain
the balance of the gut microbial ecosystem [37]. On the contrary, fat and salt usually contribute to negative
effects on gut microbiota. It has been extensively reported that the high-fat diet can promote oxidative
stress and therefore cause organ damage [35,38]. With regard to the GI tract, the alteration of dietary fat
intake (from low to high) in mice was able to shift the structure and gene expression of their gut microbiota
within one day [39]. Fleissner et al. [40] reported that the proportion of intestinal Firmicutes increased
with the increase of dietary fat consumption in mice, which was majorly due to the proliferation of the
Erysipelotrichaceae (up to 48.8% of total 16S rRNA sequences in the high-fat group), namely, one family
within the phylum Firmicutes. Apart from high-fat diet, a high-salt diet may also lead to oxidative stress
in different organs, such as the liver [34]. The gut microbiota are also sensitive to excessive salt intake.
Bier et al. [41] observed that a high-salt diet increased the abundance of taxa from the Erwinia genus,
including the families of Christensenellaceae and Corynebacteriaceae, whereas it reduced the abundance of
taxa from the Anaerostipes genus. They suggested that these changes regarding gut microbial composition
were potentially associated with the changes of short chain fatty acids (SCFAs) production. As an important
group of mediators involved in blood pressure (BP) regulation, SCFAs may play a role in the complex
diet–gut–BP interaction, which is linked to human health.
As mentioned above, the gut microbiota are sensitive to dietary change. Therefore, they are considered
as a key part involved in the variation of oxidative stress in the GI tract as well as the diseases caused
indirectly. Qiao et al. [13] reported that the development of metabolic syndrome could be affected by
the gut microbiota alterations in relation to dietary changes, and this could be indirectly associated
with changes of the redox state in the GI tract. Luca et al. [42] also reported that the imbalanced gut
microbial community, namely dysbiosis, could potentially contribute to the development of depression,
type-2 diabetes mellitus as well as Alzheimer’s disease, of which oxidative stress and inflammation are
involved. Since gut microbiota play a crucial role with regard to the diet-induced oxidative stress in the GI
tract, it is necessary to further investigate this field.
2.3. Diseases Associated with Oxidative Stress
The detrimental impacts of oxidative stress can impact the whole body. This is because the smallest
structural and functional unit, namely the cell, is directly affected by oxidative stress, in which membranes,
lipoproteins, proteins, lipids, deoxyribonucleic acid (DNA), RNA as well as ribosomes are majorly
involved [43–45]. Oxidative stress is closely associated with many diseases, especially chronic and
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degenerative diseases, such as cancer. Cancer describes a group of diseases that involve the growth of
malignant tumors or abnormal cells with the capacity to invade or spread to other parts of the body,
and destroy body tissue [46]. Various types of cancer have been reported to be linked to oxidative stress,
including liver cancer, colon cancer, pancreatic cancer, skin cancer, breast cancer, bladder cancer and
prostate cancer [47]. In addition to cancer, several neurodegenerative diseases, such as the commonly
known Parkinson’s disease and Alzheimer’s disease, have also been linked to oxidative stress [48,49].
Besides, oxidative stress is involved in the pathogenesis of many other diseases as well, either chronic or
acute, which include cardiovascular diseases [50,51], insulin resistance [52], pulmonary fibrosis [53,54],
chronic obstructive pulmonary disease (COPD) [55], muscle protein degradation [56], renal dysfunction [57],
stroke and others [58].
Interestingly, inflammation is a common cause of many chronic diseases; more specifically, it is
a biological process involved in the relevant pathogenesis since oxidative stress can activate many
transcription factors, and therefore vary the expression of certain genes involved in inflammatory
pathways [59]. For example, the level of oxidative stress-induced inflammation could be increased through
the nuclear factor kappa B (NF-κB) signaling [60]. With regard to diseases in the GI tract, inflammatory
bowel disease (IBD) is typical as an oxidative stress-associated disease. IBD describes a group of conditions
or disorders resulting in prolonged inflammation within the GI tract [61]. There are two common types
of IBD, which are Crohn’s Disease (CD) and Ulcerative Colitis (UC) [62]. It has been reported that
oxidative stress is a potential etiological factor contributing to IBD in which the ROS levels are abnormally
high [63]. Some studies reported the possible association between this kind of oxidative stress and the
composition of gut microbiota, to which the dietary structure may be linked [5,10]. Overall, diseases that
are linked to oxidative stress could be induced throughout the body where cells and tissues are damaged,
and inflammation is usually involved in the relevant pathogenesis.
3. Lactobacillus spp.
Lactobacillus spp. are a major group of lactic acid bacteria (LAB), which are Gram-positive, facultatively
anaerobic, rod-shaped as well as non-sporulating [64]. They are both oxidase- and catalase-negative,
and can ferment carbohydrates as well as hydrolyze esculin [65]. Lactobacillus spp. can be isolated from
many fermented products, such as dairy products and pickles [66,67]. Apart from that, Lactobacillus spp.
are also regular flora colonizing the GI tract and the female genital tract, where they contribute to partial
inhibition of pathogenic microorganisms due to the production of lactic acid [65]. In addition, they are
common microbial species that inhabit the human mouth, which has been reported to be associated with
dental caries [68].
The genus Lactobacillus is currently composed of 253 species, for which the names are validly
published [69]. The common species of Lactobacillus are various depending on different kinds of animals,
such as herbivores, carnivores and omnivores, which are classified by food they eat [70]. For example,
the dominant Lactobacillus spp. found in carnivores are L. johnsonii, L. reuteri, L. salivarius, L. vaginalis
as well as L. ingluviei, which are not predominant species in omnivores and herbivores [70]. Moreover,
the colonization of Lactobacillus spp. also varies within the human body, as shown in Table 1. In general,
the prevalent Lactobacillus spp. are various with regard to different parts of the human body, although some
of them are predominant in more than one place, especially within the GI tract, such as L. acidophilus,
L. plantarum and L. fermentum.
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Table 1. Common Lactobacillus spp. colonizing the human body.
Parts of the Human Body Common Lactobacillus spp. References
The GI tract
Mouth
L. acidophilus, L. gasseri,
L. fermentum, L. crispatus,
L. delbrueckii, L. salivarius,
L. paracasei, L. plantarum,
L. rhamnosus and L. oris;
[71,72]
Stomach mucosa
L. gastricus, L. antri,




L. acidophilus, L. salivarius,
L. casei, L. plantarum,
L. fermentum, L. reuterii,
L. brevis and L. rhamnosus;
[74,75]
The female genital tract
L. crispatus, L. gasseri,
L. jensenii, L. vaginalis
and L. iners.
[76]
4. Redox Role of Lactobacillus spp.
The beneficial and functional properties of Lactobacillus spp. have been extensively reported in recent
years. Apart from their contribution to diversity and functionality of the gut microbiota, it has also been
reported that they are associated with improved physiological function and cognitive ability [12,77,78].
In addition, the ameliorative impact of Lactobacillus spp. on oxidative stress has also been commonly
investigated and discussed [79,80]. Although there are many well-defined mechanisms regarding ROS
production and its relation to the gut microbiota, the redox role and relevant mechanisms of Lactobacillus
spp. are still being investigated [81]. Below, we focus on the potential redox role of Lactobacillus spp. in
modulating oxidative stress, particularly in the GI tract, based on recent research outputs.
4.1. Oxidative Stress Resistance Genes and Proteins
Genes and proteins that are resistant to oxidative stress are pivotal for the redox mechanisms of
Lactobacillus spp., since they are directly involved in the signaling pathways activated by ROS [82].
The common genes and proteins in Lactobacillus spp., which contribute to resistance towards oxidative
stress, are summarized in Table 2. The role played by thioredoxin, thioredoxin reductase as well as
their encoding genes against oxidative stress, which is called a thioredoxin antioxidant system, has been
highlighted in several studies, as shown in Table 2. Oxidative resistance genes and proteins are possessed
by a limited number of Lactobacillus spp. Thus, transformation of oxidative stress resistance genes into
valuable probiotic strains, which are deficient in such genes, has become a useful research tool. For example,
An et al. [83] co-expressed SOD and catalase genes (sodA from S. thermophilus and katA from L. sakei)
in L. rhamnosus, a valuable probiotic starter culture in industrial fermentation but which is susceptible
to oxidative stress. Co-expression of two genes remarkably improved the strains’ resistance capacity
against oxidative stress. The survival ratio of L. rhamnosus was 400-fold higher than those expressed
katA only. Similarly, co-expression of catalase and bile salt hydrolase genes (katA from L. sakei and bsh1
from L. plantarum) in L. casei also significantly improved their resistance capacity towards oxidative stress
and bile salts stress, which could be beneficial for strain performance during gastrointestinal transit and
relevant processes [84].
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Table 2. Common oxidative stress resistance genes and proteins found in Lactobacillus spp.
Lactobacillus spp. Genes/Locus Tag Encoded Proteins References
L. plantarum
trxB1 thioredoxin reductase [85]








dps1 DNA protection protein
gshR NAD(P)/FAD-dependent oxidoreductase





L. casei Shirota hprA1 HprA1 * [89]
L. sakei katA catalase [83,84]
L. brevis KatE2 heme-dependent catalase [86]




orf00,076, orf01,790 NADH oxidase




* Hpr: hydrogen peroxide resistance.
4.2. Redox Mechanisms
4.2.1. Nrf-2 Transcription Factor
Nrf-2 stands for nuclear factor erythroid 2 (NFE2)-related factor 2, which is an emerging transcription
factor that takes part in the modulation of cellular oxidative stress [92]. With regard to the genetic aspect
of Nrf-2, the expression of a number of antioxidant response element (ARE)-containing genes plays
a crucial role in the cellular defense mechanisms against oxidative stress [93,94]. On the other hand,
the pathway which consists of Kelch-like ECH-associated protein 1 (Keap 1) and Nrf-2 is also important
for modulating oxidative stress, which is majorly based on the modification of reactive cysteine residues of
Keap 1 [95]. Furthermore, glutathione peroxidase (GPx) and catalase that are implicated in Nrf-2 signaling
may contribute to the modulation of oxidative stress as well [96,97].
Li et al. [98] elucidated a possible mechanism for a L. helveticus strain regarding its potential preventive
effect on aging-related oxidative stress in a mouse model, which was through the Nrf-2 signaling.
According to the observed species index, administration of the L. helveticus strain significantly reversed
the impact of D-galactose-induced oxidative stress on the gut microbiota, returning the gut microbiome
composition to that more closely resembling the control group. Furthermore, administration of the
strain at 3 × 108 colony-forming units (CFU) resulted in roughly double the butyrate level in the cecal
contents compared to the group treated with D-galactose only. Similar findings have been reported by
Finamore et al. [99] as well, suggesting the significance of Nrf-2 for the redox role of Lactobacillus spp.
They investigated the redox protective effects of L. casei strain Shirota (a well-established isolate used
in commercial yogurt manufacture) on oxidative and inflammatory stresses in the human intestinal
Caco-2/TC7 cell line. Based on their results, L. casei Shirota helped prevent cellular ROS accumulation
as well as membrane barrier disruption. They firstly suggested a redox mechanism of L. casei Shirota,
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for which both the modulation of Nrf-2/Keap 1 signaling and inhibition of the NF-κB inflammatory
pathway contributed to the protective effect, in relation to the regulation of p65 phosphorylation and
GPx2 activity. In general, Nrf-2 seems to be an important transcription factor that some Lactobacillus spp.
commonly regulates intestinal oxidative stress through.
4.2.2. NF-κB Transcription Factor
There is a close association between NF-κB and Nrf-2 transcription factors, which depends on cell
types where oxidative stress emerges. Generally, the absence of Nrf-2 can result in increased NF-κB
activity, which contributes to more aggressive inflammation [100]. Similarly, NF-κB can also mediate the
transcriptional activity of Nrf-2 [101]. The activation of NF-κB is usually regulated by tumor necrosis factor
alpha (TNF-α), lipopolysaccharide (LPS), as well as interleukin 1 (IL-1) [102]. NF-κB plays both antioxidant
and prooxidant roles in response to oxidative stress [103,104]. Normal activation of NF-κB and the relevant
modulation of autophagy can result in protective effects, such as less ROS accumulation. In contrast,
cells could be more susceptible to oxidative stress if NF-κB and autophagy are inhibited, with enhanced
ROS formation, lipid peroxidation and protein oxidation, which are induced by TNF-α [103,104].
In addition to Nrf-2, NF-κB may be another transcription factor which plays an important role in
the redox mechanisms of Lactobacillus spp. Chen et al. [105] reported a potential association between
the inhibition of NF-κB p65 translocation administered by L. acidophilus and attenuated atherosclerotic
oxidative stress in a mouse model. Similarly, a L. brevis strain has also been reported that can alleviate the
intestinal oxidative stress through the interplay of NF-κB and MAPK (mitogen-activated protein kinase)
pathways in a mouse model [106]. Apart from the above, the NF-κB is potentially implicated in the redox
mechanisms of recombinant Lactobacillus strains as well, where certain anti-oxidative stress response genes
are transformed and expressed. Hou et al. [107] reported the ameliorative effect of sodA recombinant
L. fermentum on intestinal oxidative stress that was induced by trinitrobenzene sulfonic acid (TNBS)
in a colitis mouse model. By inhibiting the activity of NF-κB p65 subunit, they observed significantly
higher survival rate, less lipid peroxidation and less expression of pro-inflammatory cytokines in the
mouse model, which indicated decreased oxidative stress compared to mice without administration of the
recombinant strain. Although many studies have reported the potential redox role of NF-κB involved in
Lactobacillus spp., its molecular mechanisms still remain unknown at the current stage, for which further
research is required.
4.2.3. Others
With regard to other mechanisms, Toral et al. [108] reported a successful prevention of oxidative
stress-associated endothelial dysfunction and hypertension in mice, which was achieved by a L. fermentum
strain. It could be possibly due to downregulation of NOXs and prevention of endothelial nitric oxide
synthase (eNOS) uncoupling, since both mechanisms are involved in the formation process of ROS [109].
Wang et al. [110] also highlighted the importance of the downregulation of pro-inflammatory cytokines,
such as TNF-α, in modulating oxidative stress-induced UC in a mouse model. Apart from the redox role
of the strain itself, the functional products derived from Lactobacillus spp. might also contribute to the
redox mechanisms. For example, exopolysaccharide (EPS) that are produced by Lactobacillus spp. may
have the potential to alleviate oxidative stress. Li et al. [111] evaluated the ameliorative impact of EPS,
which was secreted by a L. helveticus strain, on oxidative stress. Both in vitro and in vivo tests showed
positive effects of the EPS on oxidative stress, especially towards hepatic oxidative stress, for which the
manipulation of gut microbiota composition played an important role.
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5. Potential Application
5.1. Early Treatment towards Diseases in the GI Tract
Lactobacillus spp. have the potential to be applied as an early treatment approach for many oxidative
stress-associated diseases, notably for diseases of the GI tract. As stated before, inflammation is a common
biological process involved in the pathogenesis of many diseases induced by oxidative stress, such as IBD.
Therefore, the anti-inflammatory activity of Lactobacillus spp. is regarded as a crucial aspect regarding
the modulation of diseases in the GI tract [112]. In early studies, both L. plantarum and L. fermentum
have been reported to have the potential for early treatment towards inflammation and colitis in the GI
tract [107,113]. Recently, Le and Yang [114] reported that IBD could be potentially prevented and managed
by L. plantarum, in which the modulation of the ratio of T helper cell 1 (Th1) and T helper cell 2 (Th2) plays
an important role. In addition to IBD, it has been reported that CD, which was induced by either TNBS
or a mucosal pathogen Citrobacter rodentium, could be potentially ameliorated by L. reuteri in a mouse
model [115]. Wang et al. [110] investigated the anti-inflammatory effect of L. plantarum strain ZDY2013 and
B. bifidum WBIN03 strains on dextran sodium sulphate (DSS)-induced UC in a mouse model. This study
demonstrated substantive anti-inflammatory capacity against the DSS-induced UC in mice compared to a
HT-29 cell model, which was based on downregulation of pro-inflammatory cytokines and upregulation
of antioxidant factors during the transcription process. Overall, the supplementation of probiotics, such as
Lactobacillus spp., has the potential to relieve the oxidative stress-induced inflammation in the GI tract,
which could be further considered as an early treatment approach maintaining the redox balance of the
GI tract.
5.2. Early Treatment towards Other Diseases
Many studies have discussed the in vitro and in vivo functional properties of Lactobacillus spp.
towards oxidative stress-related diseases. As probiotics, Lactobacillus spp. have already been reported that
can successfully prevent or ameliorate oxidative stress-induced inflammation in some organs, such as
liver [116]. For example, the amount of SOD and glutathione in weanling piglets could increase due to
L. fermentum administration, with the enhanced capacity to inhibit O2•− formation in muscle and liver,
which can contribute to the modulation of oxidative stress in relevant organs [117]. Recent research also
reported the preventive capacity of a L. plantarum strain, administered orally, on Di-2-ethylhexyl phthalate
(DEHP)-induced testicular damage in mice [118]. In addition, few oxidative stresses-induced cardiovascular
diseases and metabolic syndrome may be alleviated by Lactobacillus spp. as well. Chen et al. [105]
reported the potential attenuation ability of L. acidophilus ATCC 4356 on atherosclerotic progression in
Apolipoprotein-E knockout mice. Based on their results, L. acidophilus administration led to decreased
atherosclerotic lesion size without changing the body weights and profiles of serum lipid. Apart from
cardiovascular diseases such as atherosclerosis, the association between Lactobacillus spp.- and oxidative
stress-related metabolic disorders have also been extensively studied. It has been commonly reported that
type-2 diabetes mellitus could be ameliorated by probiotic supplementation, such as L. rhamnosus [97,119].
Furthermore, Lactobacillus spp. might also be associated with the mitigation of vascular oxidative stress
involved in hypertension pathogenesis [120].
In other research, Huang et al. [121] suggested a potential application of L. plantarum as an ergogenic
aid for health promotion and physiological adaptions towards exercise. They investigated the beneficial
role of L. plantarum on high-intensity exercise that is associated with oxidative stress and can further induce
inflammation and muscular damage. Based on their results, L. plantarum supplementation significantly
alleviated oxidative stress in relation to exercise, where a 55% increase of anti-inflammation cytokines
(IL-10) and a 6–13% decrease of pro-inflammation cytokines (IL-6, IL-8 and TNF-α) were observed. Besides,
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Lactobacillus spp. can also be used for the alleviation of metal toxicity. Yu et al. [122] reported the potential
protective role of L. plantarum against aluminum-induced oxidative stress as well as inflammatory response
both in vitro (HT-29 cells, intestinal tissues) and in vivo. The levels of pro-inflammatory cytokines (TNF-α,
IL-6 and IL-1β) were measured as indicators. According to their results, L. plantarum was able to partially
restore the levels of three cytokines increased due to aluminum exposure in both in vitro and in vivo
experiments, except the IL-6 levels in the colon. Overall, Lactobacillus spp. could be potentially applied to a
wide range of oxidative stress-associated diseases, in addition to those occurring in the GI tract.
5.3. Co-administration with Prebiotics
Apart from applying Lactobacillus spp. alone, co-administration of probiotics and prebiotics seems to
be an emerging research focus in recent years. Palócz et al. [113] reported that the simultaneous application
of chlorogenic acid and L. plantarum showed a great potential against lipopolysaccharide (LPS)-induced
oxidative stress and inflammation in intestinal epithelial IPEC-J2 cells. Similarly, Deol et al. [123]
investigated the effect of co-administration of ginger extract and L. acidophilus on intestinal oxidative stress
and inflammation in a mouse model. They observed that 0.4% w/v ginger extract could largely increase the
amount of L. acidophilus during a 48 to 96 h incubation. In addition, the lipid peroxidation level significantly
decreased in the co-administration group compared to the control groups where strains and ginger extract
were assigned individually. Therefore, co-administration of Lactobacillus spp. and suitable prebiotics could
be a promising approach in modulating oxidative stress and oxidative stress-induced inflammation in the
GI tract. However, further research needs to be conducted to demonstrate consistent positive impacts on
both oxidative stress and relevant diseases.
6. Conclusions
To conclude, Lactobacillus spp. show potential for the modulation of oxidative stress in cells and
tissues throughout the human body, especially in the GI tract, where they may be found naturally. Due to
their apparent role in redox reactions, Lactobacillus spp. could be utilized as probiotic supplementation for
amelioration of many oxidative stress-induced diseases, such as inflammation in the GI tract and certain
other chronic diseases. Furthermore, Lactobacillus spp. could also be administrated together with suitable
prebiotics, which may result in better antioxidative and anti-inflammatory profiles. Despite the promising
ameliorative impact of Lactobacillus spp., their mechanisms of action are still incompletely understood.
Therefore, further investigations are needed in this regard, ultimately culminating in clinical research to
ratify the extent of the possible benefits that may be realized with the use of Lactobacillus spp. to treat
human illnesses that arise from oxidative stress.
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